Search - tctmd.com

Displaying 561 - 580 of 922

Sort: Relevancy | Date

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Daily News

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

June 04, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

June 04, 2015

News Daily News

本研究建议在急性心梗后使用低剂量阿司匹林

May 28, 2015

News Daily News

Un Estudio Avala el Uso de Dosis Bajas de Aspirina Post-IAM

May 28, 2015

News Daily News

Study Supports Use of Low-Dose Aspirin After Acute MI

May 28, 2015

ACS Case 1: NSTEMI

Presentation Fellows 2015

ACS Case 1: NSTEMI

Presenter: Kevin J. Croce

May 15, 2015

News Daily News

在美国的医院中，心脏康复转诊率很低并且不一致

Yael L. Maxwell

May 13, 2015

News Daily News

Baja e Inconsistente Derivación a Rehabilitación Cardíaca en Hospitales de EE.UU.

Yael L. Maxwell

May 13, 2015

News Daily News

一项研究探讨了在ACS患者中使用普拉格雷、氯吡格雷的真实情况

May 12, 2015

News Daily News

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

May 12, 2015

News Daily News

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

May 12, 2015

News Daily News

确认房颤为非ST段抬高型心肌梗死事件的一个风险因素

May 07, 2015

News Daily News

Identificada la FA como un Factor de Riesgo de la NSTEMI Incidental

May 07, 2015

News Daily News

A-fib Identified as a Risk Factor for Incident NSTEMI

May 07, 2015

A-fib and Risk of STEMI vs NSTEMI

Presentation

A-fib and Risk of STEMI vs NSTEMI

Presenter: Elsayed Z. Soliman

May 06, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

April 29, 2015

News Daily News

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

April 28, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.